Synthesis and biological activity evaluation of dolastatin 10 (cas 110417-88-4) analogues with N-terminal modifications

Add time:08/12/2019    Source:sciencedirect.com

We have described the synthesis of the two complex units (2R,3R,4S)-dolaproine (Dap) and (3R,4S,5S)-dolaisoleuine (Dil) of dolastatin 10 (cas 110417-88-4) from natural amino acids. The stereoselective syntheses of N-Boc-Dap (4a) and N-Boc-(2S)-iso-Dap (4b) were performed by employing crotylation of N-Boc-l-prolinal as a key step. Barbier-type allylation of N-Boc-l-isoleucinal provided a mild and convenient approach for the synthesis of N-Boc-Dil (5a) and N-Boc-(3S)-iso-Dil (5b). Ten dolastatin 10 analogues have been designed and synthesized with N-terminal modifications based on the known compound monomethylauristatin F (MMAF, 3). In comparison with MMAF (3), four of the compounds showed enhanced potency against HCT 116 human colon cancer cells in vitro.

We also recommend Trading Suppliers and Manufacturers of dolastatin 10 (cas 110417-88-4). Pls Click Website Link as below: cas 110417-88-4 suppliers

Prev:Synthesis and evaluation of novel dolastatin 10 (cas 110417-88-4) derivatives for versatile conjugations
Next:High-performance capillary electrophoresis measurement of dolastatin-10)